Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in male rats

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 52-73

  Adriani, Walter ^a   Leo, Damiana ^b   Guarino, Maria ^a   Natoli, Alessia ^a   Di Consiglio, Emma ^a   De Angelis, Giovanna ^a   Traina, Elsa ^a   Testai, Emanuela ^a   Perrone Capano, Carla ^b   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

Genomic approach; Myelination; Neurotransmission; Puberty; Testosterone

Indexed keywords

ALPHA 1B ADRENERGIC RECEPTOR; ALPHA6 INTEGRIN; COLLAGEN; CONNEXIN 30; CONTACTIN; CONTACTIN 3; CONTACTIN 4; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 14; HYALURONAN MEDIATED MOTILITY RECEPTOR; LAMININ; LAMININ B1; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; METHYLPHENIDATE; OXYGENASE; POTASSIUM CHANNEL; PROTEIN ADAM 1; PROTEIN TASK 1; PROTEIN TASK 5; RAB PROTEIN; RAB13 PROTEIN; RECEPTOR; SODIUM CHLORIDE; TESTOSTERONE; TESTOSTERONE HYDROXYLASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL JUNCTION; CELL MATURATION; CELL MIGRATION; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG EFFECT; DRUG EXPOSURE; ENDOCRINE FUNCTION; ENZYME ACTIVITY; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE INDUCTION; GLIA CELL; LIVER; MALE; METABOLIC REGULATION; MICROARRAY ANALYSIS; MYELINATION; NERVE CELL; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEUROTRANSMISSION; NONHUMAN; RAT; SEXUAL BEHAVIOR; SHORT COURSE THERAPY; SPERMATOZOON COUNT; TESTIS; UPREGULATION;

EID: 33749544734     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.005     Document Type: Conference Paper

References (74)

1. SAGVOLDEN, T. & J.A. SERGEANT. 1998. Attention deficit/hyperactivity disorder-from brain dysfunction to behavior. Behav. Brain Res. 94: 1-10.
2. SONUGA-BARKE, E.J. 2003. The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci. Biobehav. Rev. 27: 593-604.
3. SWANSON, J.M. & N.D. VOLKOW. 2002. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behav. Brain Res. 130: 73-78.
4. CARLEZON, W.A. JR. & C. KONRADI. 2004. Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology 47: 47-60.
5. BRANDON, C.L., M. MARINELLI, L.K. BAKER & F.J. WHITE. 2001. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25: 651-661.
6. ANDERSEN, S.L., A. ARVANITOGIANNIS, A.M. PLIAKAS, et al. 2002. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat. Neurosci. 5: 13-14.
7. CARLEZON, W.A. JR. S.D. MAGUE & S.L. ANDERSEN. 2003. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol. Psychiatry 54: 1330-1337.
8. BOLANOS, C.A., M. BARROT, O. BERTON, et al. 2003. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol. Psychiatry 54: 1317-1329.
9. ADRIANI, W., D. LEO, D. GRECO, et al. 2005. Methylphenidate administration to adolescent rats determines short- and long-term changes on reward-related behavior and striatal gene expression. Neuropsychopharmacology Nov 23; [Epub ahead of print].
10. NESTLER, E.J. 2004. Molecular mechanisms of drug addiction. Neuropharmacology 47: 24-32.
11. BRANDON, C.L. & H. STEINER. 2003. Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur. J. Neurosci. 18:1584-1592.
12. YANO, M. & H. STEINER. 2004. Topography of methylphenidate (Ritalin)-induced gene regulation in the striatum: differential effects on c-Fos, substance P and opioid peptides. Neuropsychopharmacology 22: 1-15.
13. PIZZI, W.J., E.G. RODC, J.E. BARNHART. 1987. Differential effects of methylphenidate on the grouth of neonatal and adolescent rats. Neurotoxicol. Teratol. 9: 107-111.
14. GREELCY, G.H. Jr, J.S. KIZER. 1980. The effects of chronic methylphenidate treatment on the groth and endocrine function in the developing rat. J. Pharmacol. Exp. Ther. 215: 545-551.
15. NIH. 2005. NTP-CERHR Monograph on the potential Human Reproductive and Developmental Effects of Methylphenidate. Publication No. 05-4473.
16. MORRISSEY, R.E., B.A. SCHWEIZ, J.C. LAMB, et al. 1988. Evaluation of rodent sperm, vaginal cytology and reproductive organ weight data from National Toxicology Program 13-week studies. Fundam. Appl. Toxicol. 11: 343-358.
17. FIORINO, DF & PHILLIPS AG. 1999. Facilitation of sexual behavior in male rats following d-amphetamine-induced behavioral sensitization. Psychopharmacology 142: 200-208.
18. LURIE S & O' QUINN A. 1991. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder. J. Neuropsychiatry Clin Neurosci. 3:41-50.
19. BUDZISZEWSKA B, JAWORSKA-FEIL L. & LASON W. 1996. The effect of repeated amphetamine and coaine administration on adrenal, gonadal and thyroid hormone levels in the rat plasma. Exp. Clin. Endocrinol. Diabetes 104: 334-338.
20. MULLER E.E., LOCATELLI V, CELLA S, et al. 1983. Prolactin-lowering and releasing drugs. Mechanisms of action and therapeutic applications. Drugs 25: 399-432.
21. BECU-VILLALOBOS D, LACAU-MENGIDO IM, DIAZ-TORGA G.S., et al 1992. Ontogenic studies of the neural control of adenohypophyseal hormones in the rat. IL Prolactin. Cell. Mol. Neurobiol. 12: 1-19.
22. MEISTRICH, M.L. 1989. Evaluation of reproductive toxicity by testicular sperm head counts. J. Am. Coll. Toxicol. 8: 551-566.
23. TESTAI, E. & L. VITTOZZI. 1986. Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism. Chem. Biol. Interact. 59: 157-171.
24. OYAMA, VI. & H. EAGLE. 1956. Measurement of cell growth in tissue culture with a phenol reagent (folin-ciocalteau). Proc. Soc. Exp. Biol. Med. 91: 305-307.
25. SANWALD, P., E.A. BLANKSON, B.D. DULERY, et al. 1995. Isocratic high-performance liquid Chromatographic method for the separation of testosterone metabolites. J. Chromatogr. B 672: 207-385.
26. You, L., M. SAR, E. BARTOLUCCI, et al. 2001. Induction of hepatic aromatase by p,p'-DDE in adult male rats. Mol. Cell. Endocrinol. 178: 207-214.
27. IRIZARRY RA, HOBBS B, COLLIN F, et al 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 4: 249-264.
28. IRIZARRY, RA, BOLSTAD BM, COLLIN F. et al 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 15: c15.
29. BOLSTAD, BM, IRIZARRY RA, ASTRAND M, et al. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 22: 185-193.
30. Li C. & W.H. WONG. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci. USA 98: 31-36.
31. Li C. & W.H. WONG. 2001. Model-based analysis of oligonucleotide array: model validation, design issues and standard error application. Genome Biol. 2: 32.1-32.11.
32. LYNN, B.D., X. Li, P.A. CATTINI, et al. 2001. Identification of sequence, protein isoforms, and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain. J. Comp. Neurol. 439: 315-330.
33. NAGY, J.I., M.L. PRICE, W.A. STAINES, et al. 1998. The hyaluronan receptor RHAMM in noradrenergic fibers contributes to axon growth capacity of locus coeruleus neurons in an intraocular transplant model. Neuroscience 86: 241-255.
34. GERST, J.L., A.K. RAINA, I. PIRIM, et al. 2000. Altered cell-matrix associated ADAM proteins in Alzheimer disease. J. Neurosci. Res. 59: 680-684.
35. ROOPRAI, H.K., T. VANMETER, G.J. RUCKLIDGE, et al. 1998. Comparative analysis of matrix-metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Int. J. Oncol. 13: 1153-1157.
36. BELIEN, A.T., P.A. PAGANETTI & M.E. SCHWAB. 1999. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J. Cell Biol. 144: 373-384.
37. VAILLANT, C., M. DIDIER-BAZES, A. HUTTER, et al. 1999. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J. Neurosci. 19: 4994-5004.
38. MUIR, E.M., K.H. ADCOCK, D.A. MORGENSTERN, et al. 2002. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res. Mol. Brain Res. 100: 103-117.
39. WANG, Q., M.E. BARDGETT, M. WONG, et al. 2002. Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron 35: 25-38.
40. FARKAS, L.M., N. DUNKER, E. ROUSSA, et al. 2003. Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J. Neurosci. 23: 5178-5186.
41. KRIEGLSTEIN, K., B. REUSS, D. MAYSINGER & K. UNSICKER. 1998. Short communication: transforming growth factor-beta mediates the neurotrophic effect of fibroblast growth factor on midbrain dopaminergic neurons. Eur. J. Neurosci. 10: 2746-2750.
42. JOHNSON, M.D., M.T. JENNINGS, L.I. GOLD & H.L. MOSES. 1993. Transforming growth factor-beta in neural embryogenesis and neoplasia. Hum. Pathol. 24: 457-462.
43. REUSS, B., R. DERMIETZEL & K. UNSICKER. 1998. Fibroblast growth factor 2 (FGF-2) differentially regulates connexin (ex) 43 expression and function in astroglial cells from distinct brain regions. Glia 22: 19-30.
44. FROST, E.E., P.C. BUTTERY, R. MILNER & C. FRENCH-CONSTANT. 1999. Integrins mediate a neuronal survival signal for oligodendrocytes. Curr. Biol. 9: 1251-1254.
45. COLOGNATO, H., W. BARON, V. AVELLANA-ADALID, et al. 2002. CNS integrins switch growth factor signalling to promote target-dependent survival. Nat. Cell Biol. 4: 833-841.
46. DECKER, L. & C. FRENCH-CONSTANT. 2004. Lipid rafts and integrin activation regulate oligodendrocyte survival. J. Neurosci. 24: 3816-3825.
47. SANES, J.R., E. ENGVALL, R. BUTKOWSKI & D.D. HUNTER. 1990. Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J. Cell Biol. 111: 1685-1699.
48. SIIRONEN, J., M. SANDBERG, V VUORINEN & M. ROYTTA. 1992. Laminin B1 and collagen type IV gene expression in transected peripheral nerve: reinnervation compared to denervation. J. Neurochem. 59: 2184-2192.
49. DOYU, M., G. SOBUE, E. KEN, et al. 1993. Laminin chains gene expression in transected and regenerating nerves: regulation by axonal signals. J. Neurochem. 60:543-551.
50. DERMIETZEL, R. & H. KROCZEK. 1980. Interlamellar tight junctions of central myelin. I. Developmental mechanisms during myelogenesis. Cell Tissue Res. 213: 81-94.
51. MATHIS, C., N. DENISENKO-NEHRBASS, J.A. GIRAULT & E. BORRELLI. 2001. Essential role of oligodendrocytes in the formation and maintenance of central nervous system nodal regions. Development 128: 4881-4890.
52. DENISENKO-NEHRBASS, N., C. FAIVRE-SARRAILH, L. GOUTEBROZE & J.A. GIRAULT. 2002. A molecular view on paranodal junctions of myelinated fibers. J. Physiol. Paris 96: 99-103.
53. FALK, J., C. BONNON, J.A. GIRAULT & C. FAIVRE-SARRAILH. 2002. F3/contactin, a neuronal cell adhesion molecule implicated in axogenesis and myelination. Biol. Cell. 94: 327-334.
54. YOSHIHARA, Y., M. KAWASAKI, A. TANI, et al. 1994. BIG-1: a new TAG-1/F3-related member of the immunoglobulin superfamily with neurite outgrowth-promoting activity. Neuron 13: 415-426.
55. YOSHIHARA, Y., M. KAWASAKI, A. TAMADA, et al. 1995. Overlapping and differential expression of BIG-2, BIG-1, TAG-1, and F3: four members of an axon-associated cell adhesion molecule subgroup of the immunoglobulin superfamily. J. Neurobiol. 28:51-69.
56. Guo, J., M.R. WENK, L. PELLEGRINI, et al. 2003. Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc. Natl. Acad. Sci. USA 100: 3995-4000.
57. NAGY, J.I., D. PATEL, P.A. OCHALSKI & G.L. STELMACK. 1999. Connexin30 in rodent, cat and human brain: selective expression in gray matter astrocytes, colocalization with connexin43 at gap junctions and late developmental appearance. Neuroscience 88: 447-468.
58. RASH, J.E., T. YASUMURA, FE. DUDEK & J.I. NAGY. 2001. Cell-specific expression of connexins and evidence of restricted gap junctional coupling between glial cells and between neurons. J. Neurosci. 21: 1983-2000.
59. KUNZELMANN, P., W. SCHRODER, O. TRAUB, et al. 1999. Late onset and increasing expression of the gap junction protein connexin30 in adult murine brain and long-term cultured astrocytes. Glia 25: 111-119.
60. DERE, E., M.A. DE SOUZA-SILVA, C. FRISCH, et al. 2003. Connexin30-deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes. Eur. J. Neurosci. 18: 629-638.
61. FRISCH, C., M. THEIS, M.A. DE SOUZA-SILVA, et al. 2003. Mice with astrocyte-directed inactivation of connexin43 exhibit increased exploratory behaviour, impaired motor capacities, and changes in brain acetylcholine levels. Eur. J. Neurosci. 18: 2313-2318.
62. LESAGE, F. & M. LAZDUNSKI. 2000. Molecular and functional properties of two-pore-domain potassium channels. Am. J. Physiol. Renal Physiol. 279: F793-F801.
63. TALLEY, E.M., G. SOLORZANO, Q. LEI, et al. 2001. Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J. Neurosci. 21: 7491-7505.
64. KINDLER, C.H., C. PIETRUCK, C.S. YOST, et al. 2000. Localization of the tandem pore domain K+ channel TASK-1 in the rat central nervous system. Mol. Brain Res. 80: 99-108.
65. KARSCHIN, C., E. WISCHMEYER, R. PREISIG-MULLER, et al. 2001. Expression pattern in brain of TASK-1, TASK-3, and a tandem pore domain K(+) channel subunit, TASK-5, associated with the central auditory nervous system. Mol. Cell Neurosci. 18: 632-648.
66. CARDINAL, R.N., C.A. WINSTANLEY, T.W. ROBBINS & B.J. EVERITT. 2004. Limbic corticostriatal systems and delayed reinforcement. Ann. N. Y. Acad. Sci. 1021: 33-50.
67. PETRALIA, R.S., Y.X. WANG, N. SANS, et al. 2001. Glutamate receptor targeting in the postsynaptic spine involves mechanisms that are independent of myosin Va. Eur J. Neurosci. 13: 1722-1732.
68. HENNOU, S., A. KATO, E.M. SCHNEIDER, et al. 2003. Homer-1a/Vesl-1S enhances hippocampal synaptic transmission. Eur. J. Neurosci. 18: 811-819.
69. THOMAS, U. 2002. Modulation of synaptic signalling complexes by Homer proteins. J. Neurochem. 81: 407-413.
70. FANNING, A.S. & J.M. ANDERSON. 1999. Protein modules as organizers of membrane structure. Curr. Opin. Cell Biol. 11: 432-439.
71. MONTGOMERY, J.M., P.L. ZAMORANO & C.C. GARNER. 2004. MAGUKs in synapse assembly and function: an emerging view. Cell Mol. Life Sci. 61: 911-929.
72. CAO, Y., K.J. MURPHY, TM. MCINTYRE, et al. 2000. Expression of fatty acid-CoA ligase 4 during development and in brain. FEBS Lett. 467: 263-267.
73. ARDUINI, A., N. DENISOVA, A. VIRMANI, et al. 1994. Evidence for the involvement of carnitine-dependent long-chain acyltransferases in neuronal triglyceride and phospholipid fatty acid turnover. J. Neurochem. 62: 1530-1538.
74. ADRIANI, W. & G. LAVIOLA. 2004. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav. Pharmacol. 15: 341-352.